A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors

Research Site, New York

Research Site, New York

Research Site, The Bronx

Research Site, Marseille

Research Site, Seongnam-si

Research Site, Pittsburgh

Research Site, Philadelphia

Research Site, Fairfax

Research Site, Besançon

Research Site, Madrid

Research Site, Madrid

Research Site, Greenville

Research Site, Pamplona

Research Site, Haifa

Research Site, Bordeaux

Research Site, Miami Beach

Research Site, Tampa

Research Site, Montpellier

Research Site, Louisville

Research Site, Daegu

Research Site, Daegu

Research Site, Cleveland

Research Site, Kfar Saba

Research Site, Cincinnati

Research Site, Valencia

Research Site, Ann Arbor

Research Site, Münster

Research Site, Angers

Research Site, Busan

Research Site, Vandœuvre-lès-Nancy

Research Site, Chicago

Research Site, Chicago

Research Site, Gwangju

Research Site, Tel Aviv

Research Site, Lyon

Research Site, Pierre-Bénite

Research Site, Tübingen

Research Site, Dallas

Research Site, Houston

Research Site, San Antonio

Research Site, Aurora

Research Site, Scottsdale

Research Site, Los Angeles

Research Site, Los Angeles

Research Site, Whittier

Research Site, Duarte

Research Site, Jerusalem

Research Site, La Jolla

Research Site, Villejuif

Research Site, Portland

Research Site, Portland

Research Site, Seattle

Research Site, New Haven

Research Site, Iowa City

Research Site, London

Research Site, Toronto

Research Site, Toronto

Research Site, Montreal

Research Site, Québec

Research Site, Jena

Research Site, Amsterdam

Research Site, Amsterdam

Research Site, Tilburg

Research Site, Seoul

Research Site, Seoul

Research Site, Seoul

Research Site, Barcelona

Research Site, Barcelona

Research Site, Barcelona

Research Site, Glasgow

Research Site, London

Research Site, London

Research Site, Metropolitan Borough of Wirral

Research Site, Middlesbrough

Research Site, Oxford